Unequal crossing over between CYP11B2 and CYP11B1 causes 11 β -hydroxylase deficiency in a consanguineous family

• Published in: The Journal of steroid biochemistry and molecular biology 2023-10, Vol.233, p.106375-106375, Article 106375
• Main Authors: Xiong, Yu, Zeng, Zhen, Liang, Tingting, Yang, Pingping, Lu, Qingxiang, Yang, Jingye, Zhang, Jing, Fang, Wen, Luo, Panyu, Hu, Ying, Zhang, Miao, Zhou, Ding’an
• Format: Article
• Language: English
• Subjects: 11β-hydroxylase deficiency; Bilateral macronodular hyperplastic adrenals; Chimeric CYP11B2/CYP11B1 gene; Congenital adrenal hyperplasia; Enzymatic activity; Meiosis; Molecular docking; Pseudoprecocious puberty
• ISSN: 0960-0760; 1879-1220
• DOI: 10.1016/j.jsbmb.2023.106375

Cytochrome P450 (CYP) family CYP11B2/CYP11B1 chimeric genes have been shown to arise from unequal crossing over of the genes encoding aldosterone synthase (CYP11B2) and 11β-hydroxylase (CYP11B1) during meiosis. The activity deficiency or impaired activity of aldosterone synthase and 11β-hydroxylase resulting from these chimeric genes are important reasons for 11β-hydroxylase deficiency (11β-OHD). Here，two patients with pseudoprecocious puberty and hypokalemia hypertension and three carriers in a consanguineous marriage family were studied. A single CYP11B2/CYP11B1 chimera consisting of the promoter and exons 1 through 5 of CYP11B2, exons 8 and 9 of CYP11B1, and a breakpoint consisting of part of exon 6 of CYP11B2 and part of exon 6, intron 6, and exon 7 of CYP11B1 were detected in the patients and carriers. At the breakpoint of the chimera, a c 0.1086 G > C ( p.Leu.362 =) synonymous mutation in exon 6 of CYP11B2, a c 0.1157 C＞G(p. A386V) missense mutation in exon 7 of CYP11B1, and an intronic mutation in intron 6 were detected. The allele model of the CYP11B2/CYP11B1 chimera demonstrated homozygosity and heterozygosity in the patients and the carriers, respectively. Molecular docking and enzymatic activity analyses indicated that the CYP11B2/CYP11B1 chimeric protein interacted with the catalytic substrate of aldosterone synthase and had similar enzymatic activity to aldosterone synthase. Our study indicated that deletion of CYP11B1 and CYP11B2 abolished the enzymatic activity of 11 β-hydroxylase and aldosterone synthase; however, the compensation of the enzymatic activity of aldosterone synthase by the CYP11B2/CYP11B1 chimeric protein maintained normal aldosterone levels in vitro. All of the above findings explained the 11β-OHD phenotypes of the proband and patients in the family. •A novel single CYP11B2/CYP11B1 chimaera was detected in a Chinese consanguineous married family with 11β-OHD.•The detailed construct and sequences of the CYP11B2/CYP11B1 chimaera was firstly identified.•The allele model of the CYP11B2/CYP11B1 chimaera in the 11β-OHD family was delineated.•The enzymic activity of CYP11B2/CYP11B1 chimeric protein was firstly measured in vitro.